These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2866051)

  • 41. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.
    Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R
    Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
    Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
    J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two sisters, one with Graves' disease and the second with thyroiditis and transient hyperthyroidism.
    Tong A; Farid NR; Stenszky V
    Acta Med Acad Sci Hung; 1982; 39(1-2):7-10. PubMed ID: 6897475
    [No Abstract]   [Full Text] [Related]  

  • 44. Cell-mediated immunity in Graves' disease and in Hashimoto's thyroiditis as shown by the demonstration of migration inhibition factor (MIF).
    Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Feb; 36(2):358-64. PubMed ID: 4739173
    [No Abstract]   [Full Text] [Related]  

  • 45. The Role of Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4) Gene, Thyroid Stimulating Hormone Receptor (TSHR) Gene and Regulatory T-cells as Risk Factors for Relapse in Patients with Graves Disease.
    Eliana F; Suwondo P; Asmarinah A; Harahap A; Djauzi S; Prihartono J; Pemayun TGD
    Acta Med Indones; 2017 Jul; 49(3):195-204. PubMed ID: 29093229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic aspects of Graves' and Hashimoto's diseases.
    Kidd A; Okita N; Row VV; Volpé R
    Metabolism; 1980 Jan; 29(1):80-99. PubMed ID: 6986013
    [No Abstract]   [Full Text] [Related]  

  • 48. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Studies on the suppressor T cell function in patients with autoimmune thyroid diseases].
    Matsui J
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):925-38. PubMed ID: 6096180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunology of autoimmune thyroid diseases.
    Strakosch CR; Wenzel BE; Row VV; Volpé R
    N Engl J Med; 1982 Dec; 307(24):1499-507. PubMed ID: 6292715
    [No Abstract]   [Full Text] [Related]  

  • 52. Heterogeneity of thyrotropin binding inhibitor immunoglobulins in serum from untreated patients with hyperthyroid Graves' disease.
    Lu C; Kasagi K; Iida Y; Konishi J
    Immunol Lett; 1991 Jun; 28(3):233-6. PubMed ID: 1679417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating immune complexes and thyroid-stimulating immunoglobulins before, during, and after antithyroid drug therapy in patients with Graves' disease.
    van der Heide D; Daha MR; Bolk JH; Bussemaker JK; de Bruin TW; Goslings BM; van Es LA; Querido A
    Lancet; 1980 Jun; 1(8183):1376-9. PubMed ID: 6155582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.
    Hardisty CA; Munro DS
    Br Med J (Clin Res Ed); 1983 Mar; 286(6369):934-5. PubMed ID: 6403139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
    Hoermann R; Schumm-Draeger PM; Mann K
    Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follow up of Graves' patients thyroid stimulating antibody activity during treatment. A prospective study.
    Bakó G; Lenkey A; Szabó T; Karanyi Z; Forizs E; Kálmán K; Szabó J; Varvölgyi C; Leövey A
    Radiobiol Radiother (Berl); 1987; 28(5):600-4. PubMed ID: 2894709
    [No Abstract]   [Full Text] [Related]  

  • 57. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
    Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
    Heyma P; Harrison LC
    J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
    Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
    Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
    Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
    J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.